Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
54,053,214
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
51,666,381
-
Shares change
-
-3,003,543
-
Total reported value, excl. options
-
$242,831,448
-
Value change
-
-$8,308,464
-
Put/Call ratio
-
3.3%
-
Number of buys
-
51
-
Number of sells
-
72
-
Price
-
$4.70
Institutional Holders of Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) as of Q4 2024
As of 31 Dec 2024 Fulcrum Therapeutics, Inc. - Common Stock, $0.001 par value per share (FULC) had 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 51,666,381 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., TCG Crossover Management, LLC, BlackRock, Inc., Nantahala Capital Management, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, and Woodline Partners LP.
This table shows 117 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.